NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 21 01:20PM ET
1.90
Dollar change
-0.08
Percentage change
-4.04
%
IndexRUT P/E- EPS (ttm)- Insider Own86.88% Shs Outstand20.15M Perf Week-5.00%
Market Cap38.31M Forward P/E- EPS next Y-2.66 Insider Trans0.00% Shs Float2.64M Perf Month-62.00%
Income- PEG- EPS next Q-0.70 Inst Own13.39% Short Float13.21% Perf Quarter-58.87%
Sales- P/S- EPS this Y73.62% Inst Trans13.82% Short Ratio8.37 Perf Half Y-82.60%
Book/sh3.13 P/B0.61 EPS next Y8.76% ROA- Short Interest0.35M Perf Year-
Cash/sh3.18 P/C0.60 EPS next 5Y36.70% ROE- 52W Range1.61 - 12.30 Perf YTD-63.60%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-84.55% Beta-
Dividend TTM- Quick Ratio6.92 Sales past 5Y43.14% Gross Margin- 52W Low18.01% ATR (14)0.50
Dividend Ex-Date- Current Ratio6.92 EPS Y/Y TTM- Oper. Margin- RSI (14)28.83 Volatility20.42% 18.53%
Employees55 Debt/Eq0.14 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price19.00
Option/ShortNo / Yes LT Debt/Eq0.09 EPS Q/Q- Payout- Rel Volume1.67 Prev Close1.98
Sales Surprise-3.55% EPS Surprise22.32% Sales Q/Q- EarningsMar 27 AMC Avg Volume41.69K Price1.90
SMA20-38.57% SMA50-54.19% SMA200-68.50% Trades Volume42,744 Change-4.04%
Date Action Analyst Rating Change Price Target Change
Nov-05-24Initiated William Blair Outperform
Nov-05-24Initiated Piper Sandler Overweight $18
Nov-05-24Initiated JP Morgan Overweight $23
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Northpond Ventures II GP, LLC10% OwnerOct 15 '24Buy11.00763,6368,399,996763,636Oct 17 06:34 PM
AH Equity Partners Bio I, L.L.10% OwnerOct 15 '24Buy11.00727,2727,999,9921,579,885Oct 17 05:05 PM
Enavate Sciences GP, LLC10% OwnerOct 15 '24Buy11.001,363,63614,999,9963,785,802Oct 17 04:15 PM
Polaris Management Co. VII, L.10% OwnerOct 15 '24Buy11.00909,0909,999,990909,090Oct 15 06:00 PM
5AM Partners VI, LLC10% OwnerOct 15 '24Buy11.00909,0909,999,9902,625,145Oct 15 05:56 PM
Nashat AmirDirectorOct 15 '24Buy11.00909,0909,999,990909,090Oct 15 05:49 PM
Schwab Andrew J.DirectorOct 15 '24Buy11.00909,0909,999,9902,625,145Oct 15 05:48 PM
Cohenour JasonDirectorJun 05 '24Sale0.838,6407,1760Jun 06 09:00 AM